Measuring quality of life in inflammatory bowel disease

Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity

“…Patients with UC reported, in this study as well as in previous investigations [1,2,4], better HRQoL and general well-being and less psychological distress than patients with CD. The present study shows that these differences remain during exacerbations in disease.…”

“…Both symptoms and treatments influence patients' health-related quality of life (HRQoL) [1][2][3][4]. The concept HRQoL is subjective and multidimensional and incorporates physical, emotional, and social aspects of health perception and health functioning [1,2].…”

“…Both symptoms and treatments influence patients' health-related quality of life (HRQoL) [1][2][3][4]. The concept HRQoL is subjective and multidimensional and incorporates physical, emotional, and social aspects of health perception and health functioning [1,2]. HRQoL is impaired in UC and CD patients, as compared to a German general population (diseased or not) with reference values from the Short Form-36 (SF-36) Health Scale manual (see below) [5].…”

Quality of Life Outcomes in 599 Cancer and Non-Cancer Patients with Colostomies

“…These differences may reflect to differences in general health. Given the time since surgery, the cancer patients were likely cured of their original disease whereas those with non-cancer diagnoses, such as IBD may have continued disease exacerbations and remissions [2][3][4][5][6]. The non-cancer patients may also have had worse pre-stoma QOL with multiple GI symptoms, probably accounting for less sexual activity pre-colostomy (73% versus 58%).…”

“…Cohen et al, notes that for patients with cancer "concern about a colostomy frequently supersedes all other considerations of the patient." [1] This has also been demonstrated for patients with benign disease [2][3][4][5][6]. Colostomies for patients with cancer occur most frequently in patients with colorectal cancers, which are the third most common cancers in men (after prostate and lung cancer), and in women (after breast and lung cancer) [7].…”